Repligen (RGEN) Appoints Martin D. Madaus to Board of Directors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. QGEN
5. QS
6. BFH
7. BRO
8. SAP
9. RCUS
10. LMT

Go back to Repligen (RGEN) Appoints Martin D. Madaus to Board of Directors

Repligen Appoints Martin D. Madaus to Board of Directors

February 9, 2023 7:30 AM EST

WALTHAM, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced the appointment to its Board of Directors of life sciences tools industry leader Martin D. Madaus.

Dr. Madaus brings to the Repligen board over 25 years of industry experience, including five years as Chairman, President and Chief Executive Officer of Millipore Corporation, where he was integral to the companys transformation into a life science leader, and its acquisition by Merck KGaA in 2010. He is an active board leader, currently serving two public companies; as Lead Director for precision... More